Allianz Asset Management Gmb H Amicus Therapeutics, Inc. Transaction History

Allianz Asset Management Gmb H

$62.9 Billion
Q1 2024

A detailed history of Allianz Asset Management Gmb H transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 279,111 shares of FOLD stock, worth $2.75 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

279,111

Previous 262,332 6.4%

Holding current value

$2.75 Million

Previous $3.72 Million 11.69%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$11.43 - $14.24 $191,783 - $238,932	16,779 Added 6.4%	279,111 $3.29 Million
Q4 2023 Feb 12, 2024	BUY	$9.97 - $14.52 $74,555 - $108,580	7,478 Added 2.93%	262,332 $3.72 Million
Q3 2023 Nov 13, 2023	SELL	$11.78 - $13.86 $105,737 - $124,407	-8,976 Reduced 3.4%	254,854 $3.1 Million
Q2 2023 Aug 11, 2023	BUY	$10.72 - $13.3 $64,341 - $79,826	6,002 Added 2.33%	263,830 $3.31 Million
Q1 2023 May 11, 2023	BUY	$10.91 - $13.54 $110,420 - $137,038	10,121 Added 4.09%	257,828 $2.86 Million

Q4 2022 Feb 13, 2023	BUY	$9.89 - $12.7 $14,172 - $18,199	1,433 Added 0.58%	247,707 $3.02 Million
Q3 2022 Nov 08, 2022	BUY	$9.82 - $12.75 $2.42 Million - $3.14 Million	246,274 New	246,274 $2.57 Million
Q1 2021 May 13, 2021	SELL	$9.2 - $23.86 $555,910 - $1.44 Million	-60,425 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $813,924 - $1.5 Million	60,425 New	60,425 $1.4 Million
Q2 2020 Aug 14, 2020	SELL	$8.86 - $15.69 $391,310 - $692,964	-44,166 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$6.63 - $11.16 $676,730 - $1.14 Million	-102,071 Reduced 69.8%	44,166 $408,000
Q4 2019 Feb 13, 2020	BUY	$7.48 - $10.75 $800,442 - $1.15 Million	107,011 Added 272.81%	146,237 $1.42 Million
Q3 2019 Nov 13, 2019	BUY	$8.02 - $13.25 $4,306 - $7,115	537 Added 1.39%	39,226 $315,000
Q2 2019 Aug 08, 2019	SELL	$10.96 - $14.4 $178,878 - $235,022	-16,321 Reduced 29.67%	38,689 $483,000
Q1 2019 May 13, 2019	BUY	$10.04 - $13.92 $240,407 - $333,314	23,945 Added 77.08%	55,010 $748,000
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $1.4 Million - $2.24 Million	-166,856 Reduced 84.3%	31,065 $298,000
Q3 2018 Nov 13, 2018	SELL	$11.6 - $16.54 $5.8 Million - $8.27 Million	-499,969 Reduced 71.64%	197,921 $2.39 Million
Q2 2018 Aug 13, 2018	SELL	$13.13 - $17.09 $1.25 Million - $1.62 Million	-95,008 Reduced 11.98%	697,890 $10.9 Million
Q1 2018 May 14, 2018	BUY	$13.76 - $17.12 $22,538 - $28,042	1,638 Added 0.21%	792,898 $11.9 Million
Q4 2017 Feb 13, 2018	BUY	$12.51 - $16.24 $456,627 - $592,776	36,501 Added 4.84%	791,260 $11.4 Million
Q3 2017 Nov 13, 2017	BUY	$11.74 - $15.78 $8.86 Million - $11.9 Million	754,759	754,759 $11.4 Million

Others Institutions Holding FOLD

# of Institutions

273

Shares Held

325M

Call Options Held

841K

Put Options Held

353K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.76B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Amicus Therapeutics, Inc. Transaction History